Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Dana-Farber Cancer Institute
Tempus AI
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Roswell Park Cancer Institute
NGM Biopharmaceuticals, Inc
Kymab Limited
Stanford University
Rain Oncology Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ADC Therapeutics S.A.
Exelixis
Pfizer
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
NextCure, Inc.
Hoffmann-La Roche
Genmab
Herlev Hospital
Ludwig Institute for Cancer Research
Incyte Corporation
Duke University
Pfizer
National Institutes of Health Clinical Center (CC)
Incyte Corporation
EMD Serono
Novartis
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Novartis
National Institutes of Health Clinical Center (CC)
Beth Israel Deaconess Medical Center
Novartis
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
Altor BioScience